Search

everythinglearnresearchcommunity

for

Search:↓

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Applying a special DNA plasmid to the skin can make it thicker and stronger.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

AR gene not major factor in female hair loss; different from male hair loss.

Metabolic syndrome linked to female hair loss; waist size and high blood pressure important factors.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Metformin helps regulate menstrual cycles, induce ovulation, and improve pregnancy outcomes in women with PCOS.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Non-obese women with hair loss have higher heart disease risk.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Early diagnosis and treatment of PCOS in young people is important to prevent long-term health problems.